Doctors warned against mistaking H1N1 symptoms for common cold

AHMEDABAD: As the number of swine flu cases in Gujarat surges, state health authorities have now warned private general practitioners against writing off fever, sore throats and running noses as just common cold. On Wednesday, there were 40 swine cases registered in the state and one death.

On Wednesday, Ahmedabad city reported 17 cases, Vadodara four and Surat two. This September, 11 people have died and 448 persons contracted the H1N1 virus, of which 159 are being treated at state-run hospitals.

Kamlesh Upadhaya, the HOD of medicine at civil hospital says, “This is the season when most general practitioners overlook the initial symptoms of swine flu and prescribe medication for common cold. In cases of swine flu, the antiviral will work only if it is prescribed at the onset of the disease.”

Upadhay added that high-risk patients, including the elderly, diabetics, pregnant women, people suffering from chronic respiratory conditions and children between 5 and 15 years, must be extra cautious.

Doctors warned against mistaking H1N1 symptoms for common cold A recent study by the Government Medical College in Jamnagar corroborates Upadhaya’s observation. The study analysed 141 swine flu patients of which 115 patients survived only because they were administered oseltamivir (an antiviral) in the first 48 hours of the onset of swine flu symptoms. For the 26 patients who arrived after 48 hours of the onset of symptoms, oseltamivir was less effective. “Some 23 patients did not survive, while three survived after sufferings severe symptoms,” the study found.

Of those analysed, some 22 patients or roughly 15.6% had diabetes, 17 (12.05%) had hypertension, 32 (22.70%) had chronic obstructive pulmonary disease, 34 (24.11%) had heart disease and seven (4.96%) were pregnant women.

The study found that the most common H1N1 symptoms were cough (95.74%), followed by fever (92.20%), breathing trouble (90.78%), sore throat (71.63%) and nasal catarrh (44.68%).

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    Delhi DCA mandates digital tracking for controlled substances on new DMS portal

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

    ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers

    ICT Mumbai to host official launch of RasayanAI, bringing AI-powered drug discovery to researchers

    Six fake doctors arrested in Hyderabad

    Six fake doctors arrested in Hyderabad